| Hospice Of Presbyterian 15050 Imperial Hwy, La Mirada, CA, 90638 | |
| (562) 902-7770 |
News Archive
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.
In a speech to the American Legion today, the president will announce new steps to improve veterans' access to mental health care and the transition in getting care from the Department of Defense to VA systems.
Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.
› Verified 4 days ago
| Name | Hospice Of Presbyterian |
|---|---|
| Location | 15050 Imperial Hwy, La Mirada, California |
| Hospice ID | 051542 |
| Category | Part of a Home Health Agency |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 200 |
News Archive
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.
In a speech to the American Legion today, the president will announce new steps to improve veterans' access to mental health care and the transition in getting care from the Department of Defense to VA systems.
Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.
› Verified 4 days ago
| NPI Number | 1760487987 |
| Organization Name | Presbyterian Intercommunity Hospital Inc |
| Address | 15050 Imperial Hwy La Mirada, California, 90638 |
| Phone Number | (562)902-7763 |
News Archive
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.
In a speech to the American Legion today, the president will announce new steps to improve veterans' access to mental health care and the transition in getting care from the Department of Defense to VA systems.
Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 94.4 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 70.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.8 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 97.6 | 93.3 |
News Archive
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.
In a speech to the American Legion today, the president will announce new steps to improve veterans' access to mental health care and the transition in getting care from the Department of Defense to VA systems.
Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.
› Verified 4 days ago
| Home Health Aides | 4 |
| Counselors | 1 |
| Homemakers | 10 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 2 |
| Registered Nurses | 16 |
| Total Employees | 35 |
|---|
News Archive
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces positive headline results from the Phase 2 clinical trial of its lead product, EMA401, in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals.
A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.
In a speech to the American Legion today, the president will announce new steps to improve veterans' access to mental health care and the transition in getting care from the Department of Defense to VA systems.
Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.
› Verified 4 days ago
| Hospice Of Presbyterian Location: 15050 Imperial Hwy, La Mirada, California, 90638 Phone: (562) 902-7770 |
| Hospice Care Of California Location: 14241 E Firestone Blvd, Suite 10, La Mirada, California, 90638 Phone: (562) 902-7770 |